Novavax, Inc.
NVAX
$9.06
-$0.29-3.10%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -118.35% | 334.83% | 219.97% | 243.65% | 220.06% |
| Total Depreciation and Amortization | -50.02% | -43.06% | -25.16% | -9.42% | 0.81% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,050.18% | 5,276.15% | 7.93% | -111.68% | -91.15% |
| Change in Net Operating Assets | 76.13% | -1,931.00% | -1,914.80% | -851.28% | -176.91% |
| Cash from Operations | 51.61% | -180.34% | -316.28% | -4,518.97% | 59.91% |
| Capital Expenditure | 27.84% | 54.55% | 70.99% | 86.00% | 80.97% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 93.91% | 81.15% | 58.00% | 107.07% | -27,474.30% |
| Cash from Investing | 87.67% | 61.64% | 112.67% | 152.45% | -535.58% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -44.78% | -152.15% | -84.23% | -372.49% | -324.67% |
| Issuance of Common Stock | -97.95% | -98.01% | -98.56% | -99.93% | -29.54% |
| Repurchase of Common Stock | -693.99% | -693.99% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -90.76% | -- | -- | -- | -588.96% |
| Cash from Financing | -70.73% | -89.36% | -91.51% | -102.07% | -32.10% |
| Foreign Exchange rate Adjustments | 218.39% | 175.96% | -152.85% | -75.01% | -166.46% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 79.05% | -650.92% | -292.45% | -340.17% | -54.22% |